Anticancer vaccines.

With the tools of molecular biology and a greater understanding of mechanisms to harness the immune system, effective tumor immunotherapy is becoming a reality. This new class of therapeutics offers a more targeted, and therefore precise, approach to the treatment of cancer. The recent conditional licensure of a xenogeneic DNA vaccine for advanced canine malignant melanoma strongly suggests that immunotherapy can play an extremely important role alongside the classic cancer treatment triad components of surgery, radiation therapy, and chemotherapy.     

Land Use – Land Cover Conversion, Regeneration and Degradation in the High Elevation Bolivian Andes

Regional land-cover change affects biodiversity, hydrology, and biogeochemical cycles at local, watershed, and landscape scales. Developing countries are experiencing rapid land cover change, but assessment is often restricted by limited financial resources, accessibility, and historical data. The assessment of regional land cover patterns is often the first step in developing conservation and management plans. This study used remotely sensed land cover and topographic data (Landsat and Shuttle Radar Topography Mission), supervised classification techniques, and spectral mixture analysis to characterize current landscape patterns and quantify land cover change from 1985 to 2003 in the Altiplano (2535–4671 m) and Intermediate Valley (Mountain) (1491–4623 m) physiographic zones in the Southeastern Bolivian Andes. Current land cover was mapped into six classes with an overall accuracy of 88% using traditional classification techniques and limited field data. The land cover change analysis showed that extensive deforestation, desertification, and agricultural expansion at a regional scale occurred in the last 20 years (17.3% of the Mountain Zone and 7.2% of the Altiplano). Spectral mixture analysis (SMA) indicated that communal rangeland degradation has also occurred, with increases in soil and non-photosynthetic vegetation fractions in most cover classes. SMA also identified local areas with intensive management activities that are changing differently from the overall region (e.g., localized areas of increased green vegetation). This indicates that actions of local communities, governments, and environmental managers can moderate the potentially severe future changes implied by the results of this study.     

Lidocaine in the horse: its pharmacological effects and their relationship to analytical findings

Lidocaine is a local anaesthetic agent that is widely used in equine medicine. It is also an Association of Racing Commissioners International (ARCI) Class 2 foreign substance that may cause regulators to impose substantial penalties if residues are identified in post race urine samples. Therefore, an analytical/pharmacological database was developed for this drug. Using our abaxial sesamoid local anaesthetic model, the highest no-effect dose (HNED) for the local anaesthetic effect of lidocaine was determined to be 4 mg. Using enzyme-linked immunosorbent assay (ELISA) screening, administration of the HNED of lidocaine to eight horses yielded peak serum and urine concentrations of apparent lidocaine of 0.84 ng/mL at 30 min and 72.8 ng/mL at 60 min after injection, respectively. These concentrations of apparent lidocaine are readily detectable by routine ELISA screening tests (LIDOCAINE ELISA, Neogen, Lexington, KY). ELISA screening does not specifically identify lidocaine or its metabolites, which include 3-hydroxylidocaine, dimethylaniline, 4-hydroxydimethylaniline, monoethylglycinexylidine, 3-hydroxymonoethylglycinexylidine, and glycinexylidine. As 3-hydroxylidocaine is the major metabolite recovered from equine urine, it was synthesized, purified and characterized, and a quantitative mass spectrometric method was developed for 3-hydroxylidocaine as recovered from horse urine. Following subcutaneous (s.c.) injection of the HNED of lidocaine, the concentration of 3-hydroxylidocaine recovered from urine reached a peak of about 315 ng/mL at 1 h after administration. The mean pH of the 1 h post dosing urine samples was 7.7, and there was no apparent effect of pH on the amount of 3-hydroxylidocaine recovered. Within the context of these experiments, the data suggests that recovery of less than 315 ng/mL of 3-hydroxylidocaine from a post race urine sample is unlikely to be associated with a recent local anaesthetic effect of lidocaine. Therefore these data may be of assistance to industry professionals in evaluating the significance of small concentrations of lidocaine or its metabolites in postrace urine samples. It should be noted that the quantitative data are based on analytical methods developed specifically for this study, and that methods used by other laboratories may yield different recoveries of urine 3-hydroxylidocaine.     

Pathologic Factors Affecting Postsplenectomy Survival in Dogs

The apparently high prevalence of splenomegaly in dogs, along with the surgical accessibility of the spleen, results in a relatively large number of splenectomies in dogs in clinical veterinary practice. Splenic nodular lesions are widely considered to be indicative of hemangiosarcoma and thus a disease that is ultimately fatal. This study correlates the results of complete pathologic evaluation and classification of 500 spleens obtained by splenectomy with survival information for each dog. Among the spleens examined, 257 of 500 (51.4%) were classified nonneoplastic and 241 (48.2%) were neoplastic; 2 (0.4%) were unclassified. Miscellaneous non-nodular splenomegaly accounted for 46 of 257 (18%) of the nonneoplastic lesions; nodular splenomegaly accounted for 206 of 257 (79%) of nonneoplastic splenic lesions and was composed of lymphoid hyperplastic nodules and associated hematomas, hyperplastic lymphoid nodules alone, or hematomas with no apparent underlying cause. Nodular neoplastic diseases of the spleen were divided among benign tumors (11.5%) and a variety of primary sarcomas. Hemangiosarcoma made up 51% of splenic malignancies but accounted for less than 25% of the spleens evaluated. Survival of dogs with hematomas associated with nonneoplastic conditions of the spleen was markedly different from that in dogs with hemangiosarcoma-associated hematomas, even though most could not be effectively differentiated on gross inspection. Two month postoperative survival was 83% for dogs with nonneoplastic-related hematomas, whereas only 31% of dogs with hemangiosarcoma, with or without associated hematomas, were alive after 2 months. Twelve-month survival times were 64% and 7%, respectively. An overall postsplenectomy survival rate of 52% was based on the number of dogs surviving for a minimum of 6 months postoperatively.     

Rocky Mountain spotted fever in dogs and its differentiation from canine ehrlichiosis

Rocky Mountain spotted fever (RMSF) or ehrlichiosis was diagnosed in dogs on the basis of specific immunofluorescent testing for each disease. Comparisons between clinical and laboratory findings were made between the 2 diseases. The incidence of RMSF tended to be more seasonal and it affected younger dogs. Purebred dogs appeared to be more susceptible to both diseases. In general, RMSF had a more rapid and severe course of clinical illness than did ehrlichiosis, but acute ehrlichiosis was difficult to differentiate from RMSF. Both diseases were characterized by fever, depression, lymphadenopathy, and signs of neurologic dysfunction; petechial hemorrhages or other signs of hemorrhagic diathesis were evident only in a small proportion of cases. Anemia, leukopenia, and thrombocytopenia were more common in dogs with ehrlichiosis, whereas those with RMSF more often had leukocytosis and thrombocytopenia. Hypoalbuminemia was found in dogs with both diseases, but those with ehrlichiosis usually had concurrent hyperglobulinemia. High serum alkaline phosphatase activity and serum cholesterol concentration, and low serum calcium concentration were more common in dogs with RMSF than with ehrlichiosis. Rising serum titers or positive direct immunofluorescence for Rickettsia rickettsii in skin biopsy specimens were used to confirm RMSF, whereas a single serum titer for Ehrlichia canis enabled detection of ehrlichiosis. In the absence of neurologic deficits and when dogs were treated with tetracycline, dogs with RMSF made a more rapid and consistent recovery than did dogs with ehrlichiosis.     

Zur Holzhandelspolitik in Bayern

Ohne Zusammenfassung     

Characteristic site disturbance due to harvesting and extraction machinery traffic on sensitive forest sites with peat soils

The effects of wood harvesting and extraction machinery traffic on sensitive forest sites with peat soils were characterised with the objective of quantifying the threshold levels beyond which significant site impacts (compaction and rutting) would occur. The treatments involved running the machines in selected extraction racks (i.e., 3 m wide machine routes) while conducting normal wood thinning and extraction operations comprising one and two passes by the harvester and the forwarder with full payload, respectively. Soil disturbance thresholds were established by testing the level of significance of the difference in induced soil damage and compaction before and after machine traffic treatments. For volumetric soil water content lying between 10.0 and 14.9%, threshold cone penetration resistance levels for two 600/55–30.5 tyres were found to range from 594 to 640 kPa for deep-raised peat soil with initial strength lying between 524 and 581 kPa. In general, the proportion of the total rut depth data in each rack that exceeded the threshold level of 21.5 cm was about 5%. The threshold value corresponds to sinkage equivalent to 15% of the overall wheel diameter of the harvester, above which machine mobility would be hampered considerably. In addition, after harvester traffic the mean rut depth per unit rack length was 10.2×10⁻² cm/m, and it ranged from 0.7 to 24.7×10⁻² cm/m.